Lakefront Biotherapeutics NV annual return on equity
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Lakefront Biotherapeutics NV Return on Equity (ROE) Growth & History (LKFT)
Lakefront Biotherapeutics NV's return on equity was 10.46% for fiscal 2025.
View full Lakefront Biotherapeutics NV company overviewLakefront Biotherapeutics NV annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 10.46% | +7.86 pp |
| 2024 | 2024-12-31 | 2.60% | −5.35 pp |
| 2023 | 2023-12-31 | 7.96% | +16.39 pp |
| 2022 | 2022-12-31 | −8.43% | −4.55 pp |
| 2021 | 2021-12-31 | −3.89% | +7.13 pp |
| 2020 | 2020-12-31 | −11.01% | −18.34 pp |
| 2019 | 2019-12-31 | 7.33% | +9.96 pp |
| 2018 | 2018-12-31 | −2.63% | +10.44 pp |
| 2017 | 2017-12-31 | −13.07% | −22.68 pp |
| 2016 | 2016-12-31 | 9.61% | — |
Lakefront Biotherapeutics NV quarterly return on equity
Q2.19
Q2.20
Q2.21
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.06% | +3.99 pp |
| Q1 2026 | 2026-03-31 | 0.45% | +5.88 pp |
| Q4 2025 | 2025-12-31 | 27.53% | — |
| Q3 2025 | 2025-09-30 | −7.94% | — |
| Q2 2025 | 2025-06-30 | −3.92% | — |
| Q1 2025 | 2025-03-31 | −5.44% | — |
| Q2 2021 | 2021-06-30 | −2.41% | +1.66 pp |
| Q2 2020 | 2020-06-30 | −4.07% | −0.06 pp |
| Q2 2019 | 2019-06-30 | −4.01% | — |
Lakefront Biotherapeutics NV return on equity trends
Over the last five fiscal years, Lakefront Biotherapeutics NV's return on equity increased from −11.01% to 10.46%, a change of +21.48 percentage points. The latest reported quarter, Q2 2026, shows 0.06%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lakefront Biotherapeutics NV source filings ↗